Mepolizumab for chronic rhinosinusitis with nasal polyps (SYNAPSE

Real-Life Effectiveness of Benralizumab, Mepolizumab and Omalizumab in Severe Allergic Asthma Associated with Nasal Polyps

Mepolizumab in chronic rhinosinusitis with nasal polyposis

Life, Free Full-Text

Mepolizumab Induced Loss of Smell Improvement in Patients With Chronic Rhinosinusitis With Nasal Polyps From the SYNAPSE Study

Mepolizumab for chronic rhinosinusitis with nasal polyps: Treatment efficacy by comorbidity and blood eosinophil count - ScienceDirect

KoreaMed Synapse

Comparison of Different Biologics for Treating Chronic Rhinosinusitis With Nasal Polyps: A Network Analysis - The Journal of Allergy and Clinical Immunology: In Practice

Biomedicines, Free Full-Text

Efficacy and safety of CM310 in severe eosinophilic chronic rhinosinusitis with nasal polyps (CROWNS-1): a multicentre, randomised, double-blind, placebo-controlled phase 2 clinical trial - eClinicalMedicine

Eosinophils & MOA NUCALA (mepolizumab) for CRSwNP

Mepolizumab improvements in health-related quality of life and disease symptoms in a patient population with very severe chronic rhinosinusitis with nasal polyps: psychometric and efficacy analyses from the SYNAPSE study

Mepolizumab may reduce size of nasal polyps, need for surgery in chronic rhinosinusitis

Mepolizumab for chronic rhinosinusitis with nasal polyps (SYNAPSE): In‐depth sinus surgery analysis - Fokkens - 2023 - Allergy - Wiley Online Library

PDF) Chronic rhinosinusitis with nasal polyps (CRSwNP) treated with omalizumab, dupilumab, or mepolizumab: A systematic review of the current knowledge towards an attempt to compare agents' efficacy

FDA approves GSK's Nucala for use in adults with chronic rhinosinusitis with nasal polyps - PharmaLive